Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 5/20 | 0.40 |
| ▸ | NR1H3 | Q13133 | 4/20 | 0.40 |
| ▸ | GPR119 | Q8TDV5 | 5/20 | 0.38 |
| ▸ | ABHD6 | Q9BV23 | 3/20 | 0.37 |
| ▸ | DAGLA | Q9Y4D2 | 3/20 | 0.37 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.36 |
| ▸ | FEN1 | P39748 | 1/20 | 0.36 |
| ▸ | WNT3 | P56703 | 1/20 | 0.36 |
| ▸ | SFRP1 | Q8N474 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL406607 | 0.79 | GPR119 (0.38) | NR1H2NR1H3GPR119ALOX5APFEN1 | |
| SCHEMBL7479360 | 0.77 | CHRNB2 (0.46) | GPR119ALOX5APFEN1 | |
| SCHEMBL7407720 | 0.75 | CHRNB2 (0.53) | GPR119ALOX5APFEN1 | |
| SCHEMBL7472876 | 0.75 | CHRNA3 (0.59) | GPR119ALOX5APFEN1 | |
| SCHEMBL18291358 | 0.75 | ALOX5AP (0.50) | GPR119ALOX5APFEN1 | |
| SCHEMBL7472930 | 0.75 | CHRNB2 (0.54) | GPR119ALOX5APFEN1 | |
| SCHEMBL6588716 | 0.75 | CHRNA3 (0.59) | GPR119ALOX5APFEN1 | |
| SCHEMBL7481577 | 0.74 | ALOX5AP (0.44) | GPR119ALOX5APFEN1 | |
| SCHEMBL7408557 | 0.74 | GPR119 (0.48) | GPR119ALOX5APFEN1 | |
| SCHEMBL7455050 | 0.74 | GPR119 (0.42) | GPR119ALOX5APFEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120020881-A1 | Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2012-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120020881-A1 | Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes | KIT, STS, TST | NR1H2 3745/4885NR1H3 3597/4885GPR119 1201/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.